Skip to main content
Premium Trial:

Request an Annual Quote

Howard McLeod

Viviphi has appointed Howard McLeod to its precision medicine advisory board, and has named him senior research advisor in precision medicine. McLeod previously served in leadership positions at the H. Lee Moffitt Cancer Center's Department of Individualized Cancer Management. He also served as an endowed research chair in the state of Florida, professor at the University of South Florida, and serves as a 1000 Talent Scholar in China. Additionally, he has served on the FDA's committee on clinical pharmacology and on the National Institutes of Health's Human Genome Advisory Council.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.